214 related articles for article (PubMed ID: 38161840)
1. Prevalence of Oral Submucous Fibrosis With Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study.
S S; R S
Cureus; 2023 Nov; 15(11):e49642. PubMed ID: 38161840
[TBL] [Abstract][Full Text] [Related]
2. Knowledge About the Importance of Early Diagnosis and Treatment of Oral Potentially Malignant Disorders Among the South Indian Population: An Institutional Retrospective Study.
Kizhakkoottu S; Ramani P
Cureus; 2024 Apr; 16(4):e57740. PubMed ID: 38716030
[TBL] [Abstract][Full Text] [Related]
3. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW
Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420
[TBL] [Abstract][Full Text] [Related]
4. Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.
Kumari P; Debta P; Dixit A
Front Pharmacol; 2022; 13():825266. PubMed ID: 35517828
[TBL] [Abstract][Full Text] [Related]
5. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
6. Micronucleus Assay: An Early Diagnostic Tool to Assess Genotoxic Changes in Patients with Tobacco Use, Oral Leukoplakia and Oral Submucous Fibrosis.
Kohli M; Ahuja P; Mehendiratta M; Sharma M; Dutta J
J Clin Diagn Res; 2017 Sep; 11(9):ZC28-ZC32. PubMed ID: 29207828
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of oral potentially malignant disorders in rural areas of South India.
Jose C; Akash Medappa BK; Fareed N; Afshana TA; Battur H; Praveena J
J Cancer Res Ther; 2023; 19(3):773-777. PubMed ID: 37470609
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
Mello FW; Miguel AFP; Dutra KL; Porporatti AL; Warnakulasuriya S; Guerra ENS; Rivero ERC
J Oral Pathol Med; 2018 Aug; 47(7):633-640. PubMed ID: 29738071
[TBL] [Abstract][Full Text] [Related]
9. Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.
Rajanna VR; Raveendranath MC; Kathiresan S; Srinivasan S; Ilango J
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S382-S388. PubMed ID: 33149491
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and presentation of oral potentially malignant disorders.
Warnakulasuriya S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):582-590. PubMed ID: 29673799
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
12. Oral Potentially Malignant Disorders and Oral Cancer in Saudi Arabia: An Epidemiological Review of the Literature.
Aljohani K; Alqarni A; Harte M; Alghamdi R; Alzahrani S; Albuquerque R
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592216
[No Abstract] [Full Text] [Related]
13. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.
Yasothkumar D; Ramani P; Jayaraman S; Ramalingam K; Tilakaratne WM
Head Neck Pathol; 2024 Mar; 18(1):28. PubMed ID: 38536520
[TBL] [Abstract][Full Text] [Related]
14. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
15. Versatility of nasolabial flaps for the management of severe trismus in oral submucous fibrosis.
Balaji SM
Indian J Dent Res; 2016; 27(5):492-497. PubMed ID: 27966506
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of oral submucous fibrosis in patients visiting dental OPD of a dental college in Kanpur: A demographic study.
Srivastava R; Jyoti B; Pradhan D; Siddiqui Z
J Family Med Prim Care; 2019 Aug; 8(8):2612-2617. PubMed ID: 31548942
[TBL] [Abstract][Full Text] [Related]
17. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
18. Oral potentially malignant disorders in a large dental population.
Villa A; Gohel A
J Appl Oral Sci; 2014; 22(6):473-6. PubMed ID: 25591015
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid levels in patients with oral cancer, leukoplakia and submucous fibrosis: a cross-sectional study.
Yadav KD; Patil BA; Raheel SA; Abuderman A; Patil S; Gaballah K; Kujan O
Transl Cancer Res; 2020 Apr; 9(4):3084-3091. PubMed ID: 35117671
[TBL] [Abstract][Full Text] [Related]
20. Estimation and Comparison of Copper Content in Raw Areca Nuts and Commercial Areca Nut Products: Implications in Increasing Prevalence of Oral Submucous Fibrosis (OSMF).
Mathew P; Austin RD; Varghese SS; Manojkumar
J Clin Diagn Res; 2014 Jan; 8(1):247-9. PubMed ID: 24596787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
